EDITORIAL | VOLUME 17/ISSUE 5, SEPTEMBER 2021

Establishing a neonatal telemedicine service in Liverpool

Fauzia Paize
Consultant Neonatologist, Liverpool Women’s Hospital
fauzia.paize@lwh.nhs.uk

Simon Minford
Advanced Paediatric Nurse Practitioner and Clinical Innovation Consultant, Alder Hey Children’s Hospital

Joanne Minford
Consultant Paediatric and Neonatal Surgeon, Alder Hey Children’s Hospital

Christopher Dewhurst
Consultant Neonatologist, Liverpool Women’s Hospital

Full text available by subscription ...

The full text of this article is available to subscribers in text, and in Tablet/iPad format and as a PDF file.

Please subscribe and log in to see the full article.

Keywords

fetal renin-angiotensin system blockade; candesartan; pulmonary hypoplasia

Key points

Regular medication reviews should be undertaken for women of childbearing age.
Neonatologists should ensure that a detailed maternal medication history is taken for all babies admitted to neonatal units.
Fetal renin-angiotensin system blockade is a rare but potentially life-threatening condition. For those babies who do survive, neonatologists should ensure appropriate follow-up is put in place post-discharge.